EUVIMEDEUVIMED entdecken
Crossref

Structural optimization and anticonvulsant evaluation of aminoalkyl indole derivatives

Di Hu, Tiantian Mei, Yun Hong, Jinling Yu, Ying Wang, Hao Liu, Dachuan Liu

Bioorganic Chemistry · 2026-09 · 180 · 110211

DOI: 10.1016/j.bioorg.2026.110211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Di Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Anticonvulsants, Indoles, Seizures. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Bengbu Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of twenty-two novel aminoalkyl indole derivatives were rationally designed and synthesized via Friedel-Crafts acylation followed by nucleophilic substitution, targeting the cannabinoid receptor 2 (CB2R) as a novel approach for anticonvulsant therapy. Systematic structural optimization of the indole C-3 cycloheptanecarbonyl moiety and the N-1 aminoalkyl side chain was conducted to balance CB2R affinity, subtype selectivity, lipophilicity, and blood-brain barrier (BBB) permeability. In vitro pharmacological characterization identified compound 6d as a potent and selective CB2R agonist (EC₅₀ = 4.00 nM), with approximately 46-fold functional selectivity over CB1 receptors. In the subcutaneous pentylenetetrazole (scPTZ) seizure model, compound 6d demonstrated favorable anticonvulsant efficacy (ED₅₀ = 21.28 mg/kg, i.p.) with a high protective index (PI = 21.28), comparing favorably with the reference drug carbamazepine in both potency and safety margin. Compound 6d also exhibited favorable pharmacokinetic properties, including moderate BBB permeability (PAMPA-BBB), acceptable metabolic stability in mouse liver microsomes, sufficient brain-to-plasma exposure ratios, and negligible cytotoxicity in HepG2 cells at therapeutic concentrations. Additionally, analogue 6 g displayed moderate activity in the maximal electroshock (MES) model with a favorable safety profile. These findings indicate that the cycloheptanecarbonyl-indole scaffold represents a valuable lead structure for the development of brain-permeable, selective CB2R-targeted antiepileptic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsIndolesSeizuresAnimalsStructure-Activity RelationshipMiceHumansReceptor, Cannabinoid, CB2Molecular StructureMaleBlood-Brain BarrierDose-Response Relationship, Drug

Stichwörter der Autor:innen

AminoalkylindolesAnticonvulsantCB2 receptorEpilepsyStructure–activity relationship

Substanzen

AnticonvulsantsIndolesReceptor, Cannabinoid, CB2

Autor:innen und Institutionen

  • School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • School of Pharmacy, Bengbu Medical University, Bengbu, China; Anhui Province Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, China. Electronic address: liuhao6886@foxmail.com.
  • School of Pharmacy, Bengbu Medical University, Bengbu, China. Electronic address: dcliu1226@foxmail.com.

Förderung

  • Bengbu Medical University

Zitieren

APA

Hu, D., Mei, T., Hong, Y., Yu, J., Wang, Y., Liu, H., & Liu, D. (2026). Structural optimization and anticonvulsant evaluation of aminoalkyl indole derivatives. Bioorganic Chemistry, 180, 110211. https://doi.org/10.1016/j.bioorg.2026.110211

Vancouver

Hu D, Mei T, Hong Y, Yu J, Wang Y, Liu H, et al. Structural optimization and anticonvulsant evaluation of aminoalkyl indole derivatives. Bioorganic Chemistry. 2026;180:110211. doi:10.1016/j.bioorg.2026.110211

BibTeX
@article{Hu2026,
  author = {Hu, Di and Mei, Tiantian and Hong, Yun and Yu, Jinling and Wang, Ying and Liu, Hao and Liu, Dachuan},
  title = {Structural optimization and anticonvulsant evaluation of aminoalkyl indole derivatives},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {180},
  pages = {110211},
  doi = {10.1016/j.bioorg.2026.110211}
}
Kostenlos starten →